Ybrain is a health tech company specializing in neuromodulation devices aimed at treating mental illnesses, particularly depression. Operating in the digital healthcare market, Ybrain develops and supplies advanced headband devices that use transcranial direct current stimulation (tDCS) to large hospitals in Seoul and the metropolitan area. The company's business model revolves around the development, clinical validation, and commercialization of these medical devices, generating revenue through sales and partnerships with healthcare institutions. Ybrain's mission is to innovate healthcare through brain science, enhancing the quality of life for patients with mental health conditions. The company is committed to technological innovation and aims to lead the global market in neuroscience-based treatments. Ybrain's target clients include large hospitals and healthcare providers looking for effective, non-invasive treatment options for depression. The company has completed clinical trials and is in the process of obtaining FDA certification for its devices, positioning itself for mainstream adoption in the healthcare industry.

Keywords: neuromodulation, depression treatment, tDCS, brain science, digital healthcare, mental illness, medical devices, clinical trials, FDA certification, healthcare innovation.